-

Bayer, Microsoft Enter Into Strategic Partnership to Optimize and Advance Digital Capabilities for Food, Feed, Fuel, Fiber Value Chain

  • Bayer agronomic expertise and leading digital farming platform, combined with Microsoft Azure, form the foundation for new digital solutions to advance agriculture and adjacent industries

MONHEIM, Germany--(BUSINESS WIRE)--Today, Bayer announced a strategic partnership with Microsoft to build a new cloud-based set of digital tools and data science solutions for use in agriculture and adjacent industries, bringing new infrastructure and foundational capabilities to accelerate innovation, boost efficiency and support sustainability across value chains.

Agriculture and agribusinesses today benefit from a wide range of digital tools and data-powered insights through platforms like Bayer’s Climate FieldViewTM – used today on more than 180 million farming acres across more than 20 countries. Still, there is work to do to optimize the entire food, feed, fuel and fiber value chain and its use of the precious natural resources required to power the planet while ensuring broader efforts to combat climate change. Under the agreement, Bayer will work with Microsoft to co-develop new solutions that address critical industry scenarios such as farming operations, sustainable sourcing, manufacturing and supply chain improvement, and ESG monitoring and measurement.

The companies will do this by developing the go-forward infrastructure for digital farming solutions and data science capabilities. These new solutions and capabilities will be available to businesses – from startups to global enterprises – in agriculture and adjacent industries for use in their own offerings. Bayer will also migrate its digital farming core capabilities to the new infrastructure for its own customer-facing solutions. The partnership builds upon a longstanding relationship between Bayer and Microsoft, and a shared commitment to data privacy, cyber security and customer trust.

“This partnership comes at a unique point in time where increased innovation is sorely needed across the food and fiber value chain,” said Liam Condon, Member of the Board of Management of Bayer and President of Bayer Crop Science. “As we cope with an ongoing global pandemic, fragile supply chains and the continuing climate catastrophe, status quo will not suffice. We need collaboration, shared vision and action. For those reasons, Bayer and Microsoft are taking action to make a positive impact, both through our own collaboration as well as by offering off-the-shelf infrastructure and digital capabilities for other companies to address the enormous challenges facing our society.”

“As agriculture and technology entrepreneurs and organizations work to advance the security and sustainability of the value chain – supporting farmers at its foundation – collaboration is required,” said Jeremy Williams, Head of The Climate Corporation and Bayer Digital Farming Solutions. “Bayer is pioneering digital innovation within agriculture. Microsoft is setting the standard in trusted, global cloud solutions. Together, we can innovate and implement as a team to deliver the food, feed, fiber and fuel needed to power our planet.”

“Like every industry, farming and the food sector are undergoing rapid digital transformation, from autonomous tractors, to AI-based digital advisories, and scalable precision agriculture,” said Ravi Krishnaswamy, Corporate Vice President, Azure Global Industry at Microsoft. “We’re excited to partner with Bayer to accelerate this transformation and unlock even greater agricultural innovation by bringing together data-driven insights with Bayer’s agronomic expertise and the power of Microsoft Azure.”

This partnership is a significant, strategic step forward in accomplishing Bayer’s ambitious target of 100-percent digitally enabled sales in the Crop Science division by 2030 and accelerating its ability to deliver outcomes-based, digitally enabled solutions to customers. Bayer is committed to setting a new standard for the industry in data-driven, digital innovation.

About Bayer

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to help people and planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to drive sustainable development and generate a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2020, the Group employed around 100,000 people and had sales of 41.4 billion euros. R&D expenses before special items amounted to 4.9 billion euros. For more information, go to www.bayer.com.

xx (2021-0228)

Forward-Looking Statements

This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

Contacts

Carly Scaduto, +1 314-439-6978
Email: carly.scaduto@bayer.com

Alexander Hennig, phone +49 175 3089736
Email: Alexander.Hennig@Bayer.com

Bayer


Release Versions

Contacts

Carly Scaduto, +1 314-439-6978
Email: carly.scaduto@bayer.com

Alexander Hennig, phone +49 175 3089736
Email: Alexander.Hennig@Bayer.com

More News From Bayer

Robigo and Leaps by Bayer Announce Series A Financing to Advance Engineered Biologicals That Protect Yields and Reduce Costs

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Robigo, a biotechnology company engineering no-compromise biological solutions for crop protection, today announced a Series A funding led by Leaps by Bayer with participation from Illumina Ventures, SVG Thrive, Congruent Ventures, and Endeavor8. The round will accelerate the commercial launch of engineered microbial biopesticides combatting fungal diseases in soybeans and specialty crops in the United States, making these biologicals economically viable witho...

Bayer’s KERENDIA® (finerenone) Receives FDA Approval as the First New Treatment in 30 Years for Adults with Chronic Kidney Disease (CKD) and Type 1 Diabetes

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer Summary Bayer today announced that the U.S. Food and Drug Administration (FDA) approved KERENDIA® (finerenone) to reduce urinary albumin-to-creatinine ratio (UACR), which is expected to reduce the risk of sustained estimated glomerular filtration rate (eGFR) decline and end-stage kidney disease in adults with chronic kidney disease (CKD) associated with type 1 diabetes (T1D), following the agency’s Priority Review of the supplemental New Drug Application (...

Bayer Launches Nationwide Science Delivers Tour to Take Science on the Road

WHIPPANY, N.J.--(BUSINESS WIRE)--Amid growing concerns over misinformation around health and science, Bayer launched a nationwide tour of its Science Delivers mobile interactive experience. The mobile display hits the road at a critical moment: a Harris Poll survey of 2,023 US adults, commissioned by Bayer – Science Under Siege: The Battle Between Viral Misinformation and Shared Belief in the Value of Science (March 2026) – found that 82% worry about their own and their families' wellbeing due...
Back to Newsroom